Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Antilichaam [6G9]

Coronavirus N protein is required for coronavirus RNA synthesis, and has RNA chaperone activity that may be involved in template switch. Nucleocapsid protein is a most abundant protein of coronavirus. N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M. Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Because of the conservation of N protein sequence and its strong immunogenicity, the N protein of coronavirus is chosen as a diagnostic tool.

43740575

P0DTC9

QHD43423

Virus

Full length recombinant Nucleocapsid Protein

6G9

Unconjugated

Primary Antibodies

Infectious Disease, COVID-19

≥95 %

5.0 mg/ml (+/- 10 %)

PBS, pH 7.4

None

Blue Ice

24 months from manufacturing at <-20 &#730; C; 1 month, 2 to 8 &#730; C under sterile conditions.

Human IgG1

Antibody recognizes 2019-nCoV Nucleocapsid Protein

Immunoreactivity: 80-120 % compared to the reference sample in an ELISA test.

N

Nucleocapsid phosphoprotein

Severe acute respiratory syndrome coronavirus 2

SARS-CoV-2 (COVID-19) Nucleocapsid Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Nucleocapsid protein, N protein, Nucleocapsid Phosphoprotein

ELISA

1820552696

Liquid